| Literature DB >> 22925609 |
Pierre Balthazard1, Pierre de Goumoens, Gilles Rivier, Philippe Demeulenaere, Pierluigi Ballabeni, Olivier Dériaz.
Abstract
BACKGROUND: Recent clinical recommendations still propose active exercises (AE) for CNSLBP. However, acceptance of exercises by patients may be limited by pain-related manifestations. Current evidences suggest that manual therapy (MT) induces an immediate analgesic effect through neurophysiologic mechanisms at peripheral, spinal and cortical levels. The aim of this pilot study was first, to assess whether MT has an immediate analgesic effect, and second, to compare the lasting effect on functional disability of MT plus AE to sham therapy (ST) plus AE.Entities:
Mesh:
Year: 2012 PMID: 22925609 PMCID: PMC3518179 DOI: 10.1186/1471-2474-13-162
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Figure 1Flow chart demonstrating patient recruitment, study design and timing of data collection of Treatment groups.
Baseline characteristics of subjects (n = 42)
| Age (yrs) | 42 ± 12 | 44 ± 12 |
| Gender, ♀ (#, (%)) | 6 (30) | 8 (36) |
| Body Weight (kg) | 76 ± 13 | 71 ± 13 |
| Body Height (cm) | 174 ± 8 | 171 ± 9 |
| Body Mass Index (kg/m2) | 25 ± 5 | 24 ± 3 |
| On Sick leaves (#, (%)) | 3 (15) | 4 (18) |
| Smokers (#, (%)) | 4 (20) | 6 (27) |
All values are means ± SD, except for gender, on sick leaves and smokers.
Values of self-questionnaires (VAS-pain (average 48-hour pain); ODI; FABQ-wk; FABQ-pa) and clinical tests (Sorensen; Shirado) for the MT and ST groups before treatment, after treatment, and at 3 and 6 months after the end of treatment
| VAS-pain Average 24 hour (mm) | Pre | 22 | 65 ± 22 | 20 | 53 ± 20 |
| Post | 21 | 41 ± 29 | 18 | 28 ± 21 | |
| 3 months | 20 | 42 ± 32 | 18 | 18 ± 17 | |
| 6 months | 19 | 38 ± 32 | 18 | 23 ± 17 | |
| ODI | Pre | 22 | 32 ± 14 | 20 | 30 ± 13 |
| Post | 21 | 26 ± 15 | 18 | 20 ± 15 | |
| 3 months | 20 | 26 ± 21 | 18 | 16 ± 14 | |
| 6 months | 19 | 26 ± 25 | 18 | 16 ± 11 | |
| FABQ-wk | Pre | 22 | 20 ± 14 | 20 | 21 ± 11 |
| Post | 21 | 17 ± 13 | 18 | 17 ± 14 | |
| 3 months | 20 | 21 ± 13 | 18 | 18 ± 15 | |
| 6 months | 19 | 19 ± 13 | 18 | 18 ± 14 | |
| FABQ-pa | Pre | 22 | 15 ± 7 | 20 | 11 ± 8 |
| Post | 21 | 15 ± 7 | 18 | 13 ± 8 | |
| 3 months | 20 | 15 ± 8 | 18 | 11 ± 7 | |
| 6 months | 19 | 13 ± 8 | 18 | 11 ± 9 | |
| Sorensen (sec.) | Pre | 22 | 53 ± 50 | 20 | 57 ± 51 |
| Post | 21 | 67 ± 49 | 18 | 68 ± 58 | |
| 3 months | 20 | 78 ± 46 | 18 | 57 ± 50 | |
| 6 months | 19 | 86 ± 61 | 18 | 76 ± 47 | |
| Shirado (sec.) | Pre | 22 | 98 ± 87 | 20 | 96 ± 107 |
| Post | 21 | 102 ± 84 | 18 | 128 ± 112 | |
| 3 months | 20 | 144 ± 107 | 18 | 116 ± 99 | |
| 6 months | 19 | 158 ± 140 | 18 | 114 ± 73 | |
VAS-pain, Visual Analogue Scale of pain; ODI, Oswestry Disability Index; FABQ-wk, Fear-Avoidance Beliefs Questionnaire Work Subscale; FABQ-pa, Fear-Avoidance Beliefs Questionnaire Physical Activity Subscale; SD, standard deviation.
MT group = Manual therapy group; ST group = Sham therapy group.
Pre = before treatment; Post = after treatment; 3 and 6 months = 3 and 6 months after the end of treatment; n = number of patients.
For all scales and questionnaires, the score increases with severity of pain or symptom, except for the Sorensen and Shirado tests, wich act conversely.
Results of mixed models for primary outcomes
| Immediate effect on pain (base line = before each session) | ||||
| VAS-pain Immediate effect | Intervention | −0.76 | [−1.22;-0.30] | 0.001* |
| Time | 0.02 | [−0.03;0.06] | 0.484 | |
| Pain baseline | −0.27 | [−0.33;-0.20] | <0.001 | |
| Constant | 0.81 | [0.29;1.33] | 0.002 | |
| Treatment effect on time (base line = before treatment) | ||||
| VAS-pain Average 24 hour | Treatment | −1.24 | [−2.37;-0.11] | 0.032 |
| Time | −0.20 | [−0.69;0.29] | 0.426 | |
| Pain baseline | 0.43 | [0.17;0.69] | 0.001 | |
| Constant | 1.68 | [−0.37;3.73] | 0.108 | |
| ODI | Treatment | −7.14 | [−12.80;-1.52] | 0.013* |
| Time | −1.80 | [−3.92;0.33] | 0.097 | |
| ODI baseline | 1.95 | [1.50;2.39] | <0.001 | |
| Constant | 0.40 | [−7.88;8.68] | 0.924 | |
* Statistical significance for primary outcomes (P < 0.025).
Since the time by treatment interactions were not statistically significant, the analyses were repeated after dropping the interaction terms.
Coeff = regression coefficients: same interpretation as for ordinary (least square) regression.
CI = confidence intervals; VAS-pain, Visual Analogue Scale of pain; ODI, Oswestry Disability Index.
VAS-pain (immediate effect) was the pain difference before and after each session, and time was the number of the 8 therapeutic sessions.
VAS-pain (average 24 hour) and ODI were calculated over time, i.e., before (baseline) and after the 8th therapeutic session, as well as at 3 and 6 months after the end of the treatment.
Figure 2Effect of sham therapy (ST) and manual therapy (MT) on VAS-pain before-immediately after the intervention, for the therapeutic sessions 1 to 8. Manual therapy induces a greater immediate effect (i.e., difference between after and before) than sham therapy.
Figure 3Evolution of functional disability (ODI score) for the Manual Therapy and the Sham Therapy groups over time.
Results of mixed models for secondary outcomes
| FABQ-wk | Treatment | −1.95 | [−5.12;1.22] | 0.228 |
| Time | 1.10 | [−0.25;2.45] | 0.111 | |
| FABQ-wk baseline | 0.90 | [0.78;1.03] | <0.001 | |
| Constant | −0.75 | [−5.00;3.50] | 0.729 | |
| FABQ-pa | Treatment | 0.02 | [−3.33;3.36] | 0.992 |
| Time | −0.64 | [−1.68;0.39] | 0.223 | |
| FABQ-pa baseline | 0.61 | [0.38;0.83] | <0.001 | |
| Constant | 6.55 | [2.01;11.10] | 0.005 | |
| Sorensen | Treatment | −9.69 | [−31.70;12.30] | 0.388 |
| Time | 6.64 | [−1.63;14.90] | 0.116 | |
| Sorensen baseline | 0.51 | [0.29;0.73] | <0.001 | |
| Constant | 33.19 | [7.88;58.50] | 0.010 | |
| Shirado | Treatment | 57.40 | [1.13;113.60] | 0.046* |
| Time | 29.00 | [7.42;50.50] | 0.008 | |
| Treatment by time | −39.70 | [−69.00;-10.00] | 0.009 | |
| Shirado baseline | 0.72 | [0.54;0.90] | <0.001 | |
| Constant | 8.36 | [−36.3;53.10] | 0.714 |
* Statistical significance for secondary outcomes (P < 0.05).
Since the treatment by time interactions were not statistically significant for FABQ-wk, FABQ-pa and Sorensen, the analyses for these outcomes were repeated after dropping the interaction terms.
Coeff = regression coefficients: same interpretation as for ordinary (least square) regression.
CI = confidence intervals, FABQ-wk, Fear-Avoidance Beliefs Questionnaire Work Subscale; FABQ-pa, Fear-Avoidance Beliefs Questionnaire Physical Activity Subscale; Sorensen and Shirado tests evaluate the erector spinae and abdominal muscles endurance, respectively.
All variables were calculated over time, i.e., before (baseline) and after the 8 treatments as well as at 3 and 6 months after the end of the treatment.